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Abstract
Background: CD73 has both enzymatic and non-enzymatic functions in cells. As a nucleotidase, CD73 plays its
enzymatic function by catalyzing the hydrolysis of AMP into adenosine and phosphate. In addition to this,
accumulating data have shown that CD73 is a key regulatory molecule involved in cancer growth and metastasis,
but this non-enzymatic function of CD73 in cervical cancer cells has not been well studied.
Methods: CD73 was overexpressed by pcDNA-NT5E expression vector transfection in Hela and SiHa cells. Cell’s
proliferation and migration were evaluated by MTT and scratch healing assay. The CD73 specific antagonist -APCP
was used to inhibit CD73 enzymatic activity. And the effect of APCP on CD73 activity was determined by high
performance liquid chromatography (HPLC). Expression level was assessed by qRT-PCR and western blotting.
Results: In the present study, we used Hela and SiHa cell lines to evaluate the effects of CD73 on cervical cancer
cells proliferation and migration, and further explore the potential regulating mechanisms. Our data showed that
CD73 overexpression significantly promoted cervical cancer cells proliferation and migration, and this promotive
effect was not reverted by blocking CD73 enzymatic activity, both in Hela and SiHa cells. On the other hand, our
data also showed that high concentration of adenosine inhibited Hela and SiHa cells proliferation and migration.
These results demonstrated that the promotive effect of CD73 on cervical cancer cells proliferation and migration
in vitro was independent from its enzymatic activity (i.e. production of adenosine). Furthermore, the expressions of
EGFR, VEGF and Akt were significantly increased in CD73 overexpression Hela and SiHa cells.
Conclusions: Our data suggested that CD73 might promote proliferation and migration via potentiating EGFR/Akt and
VEGF/Akt pathway, which was independent of CD73 enzyme activity. These data provide a novel insight into the
regulating function of CD73 in cancer cells and suggest that CD73 may be promising therapeutic target in cervical cancer.
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Background
CD73 is a glycosylphosphatidylinositol (GPI) anchored
cell surface protein, also known as ecto-5’-nucleotidase
(ecto-5’-NT, EC 3.1.3.5). Accumulating data have shown
that CD73 play important roles during cancer growth
and metastasis [1–3]. CD73 has both enzymatic and
non-enzymatic functions [4]. As an enzyme, CD73
catalyzes the AMP breakdown into adenosine. Notably,
adenosine is an important purine signaling molecule
which has been found to be involved in tumor immu-
noescape [5]. In addition to its enzymatic function,
CD73 is also a regulatory molecule which related to
cancer invasive and metastatic properties [3, 6, 7].
Studies have found that CD73 can promote proliferation
and migration of several types of cancer cells [6, 8–10].
Cervical cancer, a cancer arising from cervix is due to
the abnormal proliferation of cells that have the ability
to evade growth suppression. Cervical cancer is high in
the rank of cancers affect women, with both the fourth-
highest incidence and the fourth-highest fatality rate
among women worldwide [11]. Infection with several
special types of human papilloma virus (HPV) has been
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found to be the most high-risk cause of cervical cancer
[12]. However, HPV infection was not enough to trigger
cervical cancer. Other factors, like molecular alteration
have also been found to play important role during cervical
cancer development [13, 14]. The role of CD73 in cervical
cancer cells has not been well studied. In the present study,
we investigated the effect of CD73 overexpression on cer-
vical cancer cells proliferation and migration, and further
explored its underlying regulatory mechanisms. Our data
demonstrated that CD73 overexpression promoted Hela
and SiHa cells proliferation and migration. Moreover, this




Two human cervical cancer cell lines, Hela and SiHa
(American Type Culture Collection, ATCC), were used in
this study. The cells were cultured in DMEM medium
(Gibco, Carlsbad, NY, USA) supplemented with 10%
heat-inactivated Fetal bovine serum (FBS, Sijiqing Biotec,
Hangzhou, China) at 37 °C with 5% CO2 in a humidified
incubator.
pcDNA-NT5E recombinant expression vector construction
and transfection
CD73 coding gene - NT5E was cloned into the pcDNA3.0
+ expression vector, then, the pcDNA-NT5E and control
plasmids were transfected into Hela and SiHa cells using
Lipofecta-mine™ 2000 reagent (Invitrogen, Carlsbad CA,
USA) following the protocol offered by the manufacturer.
Briefly, parental Hela and SiHa cells (3 × 105/well) were
plated in six - well plate and cultured until 70 – 80% con-
fluence. Premixed lipofection and plasmid DNA (10 μl :
4 μg) were added into the wells and incubated for 24 h.
And then, the transfected cells were screened by G418.
CD73 activity assay
The conversion of AMP to adenosine was measured to
assess the CD73 activity. Cultured cells were collected and
suspended in DHank's buffer at a density of 4 × 105 cells/
ml. 500 μl cell suspension was incubated with 1 mM
AMP at 37 °C for 1 h, the effect of APCP on CD73 activity
was investigated by adding 50 μM APCP into reaction
system. Subsequently, cells were centrifuged, and the
supernatants (10 μl) were subjected to HPLC analysis
(Shimadzu, LC-2030c; column: GL Sciences, C18, 3.5 μm,
2.5 × 250 mm). Adenosine was extracted through a 0-50%
methanol/H2O phase gradient elution (1 ml/min). The
absorbance was measured at 259 nm. The peak volume
(PV) for adenosine was calculated using LabSolutions LC
Workstation Ver.5.
MTT cell viability assay
The cells were seeded in 96 - well plate at a density of 4 ×
103 cells per well and cultured at 37 °C in DMEM medium
plus 10% FBS. At different time point, 10 μl of MTT
(5 mg/ml, Amresco, Solon, USA) was added into each well
and the cells were incubated for another 4 h at 37 °C. The
supernatants were then discarded carefully and 150 μl
DMSO was added to each well. The plate was shaken for
additional 10 min and the absorbance value was measured
at 490 nm by using the microplate reader (Bio-Rad,
Hercules, USA). The relative viability of cells was calcu-
lated as a percentage using the formula: (mean OD490 of
treated cells/mean OD490 of control cells) × 100%.
Migration assays
Migration ability of the cells was examined by scratch assay.
Transfected and control cells were cultured in six-well plate.
The scratch was performed with a pipette tip when cell
density reached to 80%. Once scratch was made, cells were
gently washed by PBS twice, following cultured with serum-
free medium. Images were captured immediately, and 24 h
after the scratch was made. The cell migration distance was
measured by HMIAS - 2000 software. The migration ability
of cells was mirrored by relative migration ratio: Relative mi-
gration ratio = (Start distant – End distance)/Start distance.
Quantitative real-time RT-PCR and western-blot analysis
Quantitative real-time RT-PCR was carried out using the
SYBR Green kit (Invitrogen, Carlsbad, USA) according to
the manufacturer’s instructions. The relative expression
levels of genes were normalized to the endogenous house-
keeping gene β-actin. The primer sequence are list in
Table 1. For western-blot, the total cell protein was loaded
for SDS-PAGE, and then transferred onto polyvinylidene
difluoride membranes. Membranes were blocked with 5%
non-fat dried milk for 2 h at room temperature, and then
incubated with primary antibody (R & D Systems, Inc.)
overnight at 4 °C. After washed with TBST for three times,
membranes were incubated with secondary antibody for
2 h at room temperature. After washed with TBST, proteins
were detected with western blotting luminol reagent (Santa
Cruz Biotechnology, Santa Cruz, USA), β-actin were used
as the internal standard.
Table 1 primer sequence used in the study
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Fig. 1 The proliferation and migration of CD73 overexpression cells. a, b RT-PCR and western-blot showed that CD73 expression in transfected
cells (named Hela-CD73 and SiHa-CD73) was significantly high than that in control cells. c MTT assay showed that CD73 overexpression promoted
Hela and SiHa cells proliferation. d Scratch healing assay showed that CD73 overexpression promoted Hela and SiHa cells migration
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Statistical analysis
All data were confirmed in three biological replicates. The
data are expressed as the mean ± standard error. Data
comparisons were conducted by using the Student’s t-test.
P < 0.05 was considered to be statistically significant.
Results
CD73 overexpression promoted proliferation and
migration of cervical cancer cells
To determine the effect of CD73 in proliferation and mi-
gration of human cervical cancer cells in vitro, the
pcDNA-NT5E and control vectors were constructed and
transfected into Hela and SiHa cells. The expression
level of CD73 in transfected cells was significantly higher
than that in mock and parental control cells (Fig. 1a),
and the CD73 enzymatic activity was also increased in
CD73 overexpressed cancer cells (Additional file 1:
Figure S1). Then, the effect of CD73 overexpression on
cervical cancer cells proliferation and migration was ex-
amined. By using MTT assay, we found that the prolifer-
ation rate of CD73 overexpression cells was significantly
higher than that of control cells (Fig. 1b). Moreover, in
addition to the promotive effect of CD73 on Hela and
SiHa cells proliferation, we also found that CD73 over-
expression enhanced the Hela and SiHa cells migration
ability by using scratch healing assay (Fig. 1c). These re-
sults demonstrated that CD73 overexpression promoted
cervical cancer cells proliferation and migration in vitro.
Blocking of CD73 enzyme activity could not revert its
promotive effect on cells proliferation and migration
CD73 has both enzymatic and non-enzymatic function. To
further investigate whether the promotive effect of CD73 on
the cells proliferation and migration was dependent on its en-
zyme activity or was mainly the results of its non-enzymatic
function, we used 50 μM APCP (the specific inhibitor of
CD73 enzymatic activity) to block the CD73 enzyme activity
in the present study. HPLC analysis showed that APCP could
inhibit CD73 enzymatic activity significantly. (Additional file
1: Figure S1). Moreover, APCP treatment did not influence
the proliferation and migration of CD73 transfected Hela and
SiHa cells (Fig. 2), which means that the promotive effect of
CD73 is not reverted by blocking of CD73 enzymatic activity.
These results indicated that the promotive effect of CD73
overexpression on the proliferation and migration of Hela
and SiHa cells was independent of its enzyme activity.
Fig. 2 The effect of APCP on CD73 transfected Hela and SiHa cells. a MTT assay showed that APCP treatment did not influence the proliferation
of CD73 overexpression Hela and SiHa cells. b The migration of CD73 transfected cells was not changed in response to APCP treatment. These
results suggested that APCP treatment did not revert the promotive effect of CD73 overexpression
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High concentration of extracellular adenosine decreased
cervical cancer cells proliferation and migration
As a nucleotidase, CD73 catalyzed AMP breakdown into
adenosine. In present study, we examined the effect of ad-
enosine in cervical cancer cells proliferation and migration
in vitro. Hela and SiHa cells were treated with different
concentrations (1, 10, 50, 100 nM; 1, 5, 10, 100, 500 μM;
1, 5, 10 mM) of adenosine for 24 h and 48 h. After adeno-
sine treatment, MTT assay was used to detect the cancer
cells proliferation. As shown in Fig. 3, compared with
control cells, the proliferation rate was inhibited by high
concentration (>100 μM) of extracellular adenosine in
both Hela and SiHa cells, while the cells proliferation was
not influenced by low concentration (<100 μM) of
adenosine. Moreover, treatment with high concentration
of adenosine significantly diminished migration ability of
Hela and SiHa cells (Fig. 3). These results suggested that
the promotive effect of CD73 overexpression on prolifera-
tion and migration in vitro was independent of adenosine
(i.e. CD73 enzyme activity).
CD73 overexpression potentiated EGFR/Akt and VEGF/Akt
pathway
Since the promotive effect of CD73 on the cells prolifera-
tion and migration was independent of its enzyme activity,
there should be other mechanism involved in this promo-
tive function. EGFR and VEGF are crucial signaling mole-
cules which have been believed to promote cancer cell
growth and metastasis. In this present study, we examined
the effect of CD73 overexpression on EGFR and VEGF ex-
pression in cervical cancer cells. As shown in Fig. 4, com-
pared with control cells, the EGFR expression was
increased by 62% and 45%, while VEGF was increased by
76% and 69% in CD73 transfected Hela and SiHa cells. As
Akt is an important downstream signaling molecule of
EGFR and VEGF, we also investigated the change of Akt
expression in CD73 overexpression cervical cancer cells.
The RT-PCR and western-blot results showed that the ex-
pression of both Akt and phospho-Akt were significantly
increased in CD73 transfected Hela and SiHa cells than
that in control cells. These data suggested that CD73 over-
expression potentiated EGFR/Akt and VEGF/Akt pathway.
Furthermore, to rule out the possibility that these signaling
molecules changes were induced by the CD73 enzyme ac-
tivity, we examined the effect of APCP treatment on EGFR,
VEGF and Akt expression. As shown in Fig. 4, the mRNA
and protien expressions of these molecules in CD73
overexpression cells were not changed in response to
APCP treatment (Fig. 4a, b). And moreover, we also
investigated whether adenosine changed these mole-
cules levels by qRT-PCR, the results were negative
Fig. 3 The effect of extracellular adenosine on cells proliferation and migration. a Gradient adenosine treated Hela and SiHa cells. The results
showed that high concentration of adenosine inhibits cells proliferation. b Scratch healing assay showed that high concentration of adenosine
diminished the migration of Hela and SiHa cells
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(Additional file 2: Figure S2). Thus taken together,
these data indicated that CD73 ovexpression promoted
Hela and SiHa cells proliferation, at least partially, via po-
tentiating the EGFR/Akt and VEGF/Akt signaling path-
way, independent of CD73 enzymatic activity.
Discussion
CD73 has emerged as an important molecule during
cancer growth and metastasis. This study was under-
taken to evaluate the effect of CD73 on cervical cancer
cells proliferation and migration. Our results showed
that CD73 overexpression promoted cervical cancer cells
proliferation and migration in vitro. CD73 has both
enzymatic and non-enzymatic functions in cells. As a
nucleotidase, CD73 catalyzes AMP breakdown into ad-
enosine. CD73-generated adenosine has been recognized
an important purinergic signaling during cancer progres-
sion, which can suppress immune response and assist
tumor immune evasion in vivo via multiple pathway [5].
However, besides evading immune destruction, rapid
and un-controlled proliferation of tumor cells is another
key factor for cancer growth [15]. Regard to this, recent
years, researchers investigated the direct effect of extra-
cellular adenosine on cancer cells proliferation in vitro
by adding adenosine into culture medium, these data, in-
cluding ours here, have shown that high concentration
of adenosine can inhibit tumor cells proliferation and
migration [16–19]. However, this inhibiting effect of
high concentration of adenosine is unexpected, since
CD73 overexpression has been found to promote tumor
cells proliferation and migration in vitro.
At first sight, the promotive effect of CD73 and inhibiting
effect of adenosine on cervical cancer cells proliferation and
migration seemed to be paradoxical. This apparent discrep-
ancy could be explained on the basis of the following con-
siderations. The concentration of adenosine is determined
by a complex ectoenzyme mechanism. The generation and
degradation of adenosine is catalyzed by a cascade of en-
zyme as follows: ATP/ADP breakdown into AMP by CD39,
AMP breakdown into adenosine by CD73, and adenosine
breakdown into inosine by ADA and its cofactor CD26.
Thus, the increased concentration of adenosine by CD73
overexpression may be not enough to inhibit the cancer cells
proliferation and migration (the adenosine concentration
should be > 100 μM, which can display inhibited effects). As
the low concentration of adenosine has no effect on cancer
cells proliferation and migration, therefore, the promotive
effect of CD73 overexpression on cells proliferation and
Fig. 4 CD73 overexpression potentiated EGFR/Akt and VEGF/Akt pathway. a RT-PCR and b western-blot showed that the expressions of EGFR,
VEGF, Akt, pAkt were significantly higher in CD73 overexpression Hela and SiHa cells in compared with control cells, and moreover, increased
effect in CD73 overexpression cells was not reverted by APCP treatment
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migration in vitro were independent of its enzyme activity.
Indeed, here we proved this hypothesis in Hela and SiHa
cells. In present study, we found that the promotive effect of
CD73 overexpression on cervical cancer cells proliferation
and migration were not reverted by blocking of CD73 en-
zyme activity. These data suggested that CD73 promoted
cervical cancer cells proliferation and migration, which was
dependent of its non-enzyme activity. EGFR and VEGF have
been believed to promote cancer growth and metastasis
[20–23]. Co-expression of CD73 and EGFR or VEGF has
been found in other type of cancers [24–26]. Consistently,
in this study, we found that EGFR and VEGF expression
were markedly increased in CD73 transfected cervical
cancer cells. Although Zhi X’s data have suggested that
CD73 may promote EGFR expression though regulating
some associated transcription factor, such as PPARγ [24].
However, the relevant studies are still few to demonstrate
the regulated mechanism of CD73 on expression of EGFR
and VEGF. The interaction among them needs further stud-
ies. Moreover, the Akt expression, which is an important
downstream molecule of EGFR and VEGF, was also signifi-
cantly higher in CD73 overexpression cells than that in
control cells [27]. In the mean while, the EGFR, VEGF and
Akt expression in CD73 overexpression cells were not chan-
ged in response to APCP treatment. In summary, our data
suggest that CD73 overexpression promote cervical cancer
cells proliferation and migration, via potentiating EGFR/Akt
and VEGF/Akt pathway, independent of its enzymatic activ-
ity. These data provide a novel insight into the regulating
function of CD73 in cancer and suggest that CD73 may be
promising therapeutic target in cervical cancer.
Conclusions
Our data showed that CD73 promoted cervical cells prolif-
eration and migration, and this promotive effect was inde-
pendent of CD73 enzyme activity. In addition, we also
showed that CD73 overexpression potentiated EGFR/Akt
and VEGF/Akt pathway. These data provide a novel insight
into the regulating function of CD73 in cancer cells and
suggest that CD73 may be promising therapeutic target in
cervical cancer.
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